Exicure Inc banner

Intrinsic Value

Not Available for 2H0

There is not enough data to reliably calculate the intrinsic value for Exicure Inc.

Do our valuations actually work? See backtest results .

Alternatives to 2H0

Fundamental Analysis

What Exicure Does

Biotechnology Health Care

Exicure is a biotechnology company that develops experimental medicines based on spherical nucleic acid, or SNA, technology. Its core work is to design and test drug candidates that aim to turn genes on or off more precisely than traditional medicines, with the goal of treating serious diseases.

Headquarters
United States of America US
Employees
8
IPO date
May 9, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Exicure Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

XCUR Insider Trading
Buy and sell transactions by insiders